Pain Management

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC77-3

DiraChart Clinical Reference
Protected section 3 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 15PreviousNext

2. What to assess, technique, and required data

Assess pain validly and reassess effect:

  • For residents who can self-report: PQRST (provocation, quality, region/radiation, severity 0–10, timing) and the effect on function and sleep.
  • For residents who cannot self-report (advanced dementia, nonverbal): an observational scale such as PAINAD (breathing, vocalization, facial expression, body language, consolability).
  • The plan, the pharmacologic/non-pharmacologic intervention delivered, and the reassessed effect with the time of reassessment; for opioids, sedation, respiratory status, and the bowel regimen.

MDS-supportive data

Pain frequency, intensity, and its effect on function/sleep are coded in MDS Section J (J0100–J0850); opioid days in Section N. The record must document the assessment and effect so Section J is supported (F641).

Section NavigationPart 3 of 15PreviousNext